Interleukin-5
| GO Term | Evidence Code | Reference |
|---|---|---|
| positive regulation of immunoglobulin production | ||
| inflammatory response | ||
| immune response | ||
| positive regulation of B cell proliferation | ||
| interleukin-5-mediated signaling pathway |
| GO Term | Evidence Code | Reference |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| obsolete extracellular space |
|
|
| GO Term | Evidence Code | Reference |
|---|---|---|
| cytokine activity | ||
| cytokine activity | ||
| cytokine activity | ||
| interleukin-5 receptor binding | ||
| interleukin-5 receptor binding |
| Position | Description |
|---|---|
| 90 | Not glycosylated |
| Pathway Name | Organism |
|---|---|
| Differentiation of naive CD4+ T cells to T helper 2 cells (Th2 cells) | Homo sapiens |
| Interleukin receptor SHC signaling | Homo sapiens |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | Homo sapiens |
| RAF/MAP kinase cascade | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:10534 | stomach cancer | |
| DOID:2841 | asthma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026